Dr Faraz Ali
Teams and roles for Faraz Ali
Publication
2025
2024
- Johns, J. R. et al. 2024. The Dermatology Life Quality Index as the primary outcome in randomized clinical trials: a systematic review. British Journal of Dermatology 191 (4), pp.497-507. (10.1093/bjd/ljae228)
- Shah, R. et al. 2024. Measurement of the major ignored burden of multiple myeloma, pernicious anaemia and of other haematological conditions on partners and family members: A cross‐sectional study. European Journal of Haematology 113 (1), pp.117-126. (10.1111/ejh.14206)
- Shah, R. et al. 2024. Mapping of family reported outcome measure (FROM-16) scores to EQ-5D: algorithm to calculate utility values. Quality of Life Research 33 , pp.1107-1119. (10.1007/s11136-023-03590-z)
- Shah, R. et al. 2024. Dementia and its profound Impact on family members and partners. Alzheimer Disease & Associated Disorders 38 (4), pp.338-342. (10.1097/WAD.0000000000000647)
- Vyas, J. et al. 2024. The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality of life instruments: A systematic review. Journal of the European Academy of Dermatology and Venereology (10.1111/jdv.20321)
- Vyas, J. et al. 2024. A systematic review of 207 studies describing validation aspects of the dermatology life quality index. Acta Dermato-Venereologica 104 adv41120. (10.2340/actadv.v104.41120)
- Vyas, J. et al. 2024. A systematic review of 457 randomised controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries. British Journal of Dermatology 190 (3), pp.315-339. (10.1093/bjd/ljad079)
2023
2021
- Abdelrazik, Y. T. et al. 2021. Clinical experience and psychometric properties of the Cardiff Acne Disability Index (CADI). British Journal of Dermatology 185 (4), pp.711-724. (10.1111/bjd.20391)
- Ali, F. M. 2021. Evaluating quality of life measurement in psoriasis and the development of new solutions to improve the use of patient-reported outcomes. PhD Thesis , Cardiff University.
- Bardazzi, F. et al., 2021. The impact of psoriasis on quality of life of children and their caregivers: an Italian experience. European Journal of Dermatology 31 (5), pp.649-650. (10.1684/ejd.2021.4127)
- Shah, R. et al. 2021. Family reported outcomes, an unmet need in the management of a patient's disease: appraisal of the literature. Health and Quality of Life Outcomes 19 194. (10.1186/s12955-021-01819-4)
- Shah, R. et al. 2021. Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey. BMJ Open 11 (5) e047680. (10.1136/bmjopen-2020-047680)
- Wójcik, E. et al., 2021. Major life changing decision profile: Creation of the Polish language version. Dermatologic Therapy 34 (1) e14568. (10.1111/dth.14568)
2020
2019
2018
2017
2015
2011
Articles
- Abdelrazik, Y. T. et al. 2021. Clinical experience and psychometric properties of the Cardiff Acne Disability Index (CADI). British Journal of Dermatology 185 (4), pp.711-724. (10.1111/bjd.20391)
- Ali, F. et al. 2017. A systematic review of the use of quality-of-life instruments in randomised controlled trials of psoriasis. British Journal of Dermatology 176 (3), pp.577-593. (10.1111/bjd.14788)
- Ali, F. et al. 2011. X-linked dominant protoporphyria due to a novel mutation in ALAS2: a case report [Abstract]. British Journal of Dermatology 164 (5), pp.1167-1167. (10.1111/j.1365-2133.2011.10357.x)
- Ali, F. et al. 2018. Correlating the Dermatology Life Quality Index with psychiatric measures: A systematic review. Clinics in Dermatology 36 (6), pp.691-697. (10.1016/j.clindermatol.2018.08.014)
- Ali, F. , Salek, M. S. and Finlay, A. 2018. Two minimal clinically important difference (2MCID): A new twist on an old concept. Acta Dermato Venereologica 98 (7), pp.715-717. (10.2340/00015555-2894)
- Ali, F. , Vyas, J. and Finlay, A. Y. 2020. Counting the burden: atopic dermatitis and health-related quality of life. Acta Dermato-Venereologica 100 (12) adv00161. (10.2340/00015555-3511)
- Ali, F. M. and Finlay, A. Y. 2025. Uncovering the life-long impact of skin disease on major life changing decisions [Editorial]. Acta Dermato-Venereologica 105 adv43472. (10.2340/actadv.v105.43472)
- Ali, F. M. et al. 2017. Comparison of the paper-based and electronic versions of the Dermatology Life Quality Index (DLQI): evidence of equivalence. British Journal of Dermatology 177 (5), pp.1306-1315. (10.1111/bjd.15314)
- Ali, F. et al. 2019. Validation of the electronic Psoriasis Area and Severity Index application: establishing measurement equivalence. Journal of The American Academy of Dermatology 81 (6), pp.1439-1441. (10.1016/j.jaad.2019.04.073)
- Bardazzi, F. et al., 2021. The impact of psoriasis on quality of life of children and their caregivers: an Italian experience. European Journal of Dermatology 31 (5), pp.649-650. (10.1684/ejd.2021.4127)
- Campbell, N. et al., 2015. Equivalence of electronic and paper-based patient-reported outcome measures. Quality of Life Research 24 (8), pp.1949-1961. (10.1007/s11136-015-0937-3)
- Cueva, A. et al., 2025. Psychometric validation of the Spanish for Ecuador Family Reported Outcome Measure (FROM-16) and its application to measure impact on family members of patients with skin diseases. Journal of Patient-Reported Outcomes 9 (1) 51. (10.1186/s41687-025-00866-5)
- Hasan, S. , Ali, F. and Ingram, J. 2020. Cholinergic pruritus responding to Omalizumab. Clinical and Experimental Dermatology 45 (2), pp.264-266. (10.1111/ced.14052)
- Johns, J. R. et al. 2024. The Dermatology Life Quality Index as the primary outcome in randomized clinical trials: a systematic review. British Journal of Dermatology 191 (4), pp.497-507. (10.1093/bjd/ljae228)
- Marron, S. E. et al., 2018. The psychosocial burden of hand eczema: Data from a European dermatological multicentre study. Contact Dermatitis (10.1111/cod.12973)
- Pawlak, Z. et al., 2023. Translation and validation of the Polish language version of the Teenagers Quality of Life questionnaire (T-QoL). Postępy Dermatologii i Alergologii 40 (6), pp.753-756. (10.5114/ada.2023.133584)
- Shah, R. et al. 2021. Family reported outcomes, an unmet need in the management of a patient's disease: appraisal of the literature. Health and Quality of Life Outcomes 19 194. (10.1186/s12955-021-01819-4)
- Shah, R. et al. 2024. Measurement of the major ignored burden of multiple myeloma, pernicious anaemia and of other haematological conditions on partners and family members: A cross‐sectional study. European Journal of Haematology 113 (1), pp.117-126. (10.1111/ejh.14206)
- Shah, R. et al. 2024. Mapping of family reported outcome measure (FROM-16) scores to EQ-5D: algorithm to calculate utility values. Quality of Life Research 33 , pp.1107-1119. (10.1007/s11136-023-03590-z)
- Shah, R. et al. 2024. Dementia and its profound Impact on family members and partners. Alzheimer Disease & Associated Disorders 38 (4), pp.338-342. (10.1097/WAD.0000000000000647)
- Shah, R. et al. 2021. Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey. BMJ Open 11 (5) e047680. (10.1136/bmjopen-2020-047680)
- Shah, R. et al. 2025. Comparison of the impact of type 1 and type 2 diabetes on quality of life of families of patients: A UK cross‐sectional study. Diabetes, Obesity and Metabolism 27 (2), pp.652-662. (10.1111/dom.16058)
- Shah, R. et al. 2023. Meaning of Family Reported Outcome Measure (FROM-16) severity score bands: a cross-sectional online study in the UK. BMJ Open 13 (3) e066168. (10.1136/bmjopen-2022-066168)
- Vyas, J. et al. 2024. The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality of life instruments: A systematic review. Journal of the European Academy of Dermatology and Venereology (10.1111/jdv.20321)
- Vyas, J. et al. 2025. A systematic review of the use of the Dermatology Life Quality Index (DLQI) in routine clinical practice: evidence from 287 articles across 56 countries. Clinical and Experimental Dermatology 50 (12), pp.2456-2465. (10.1093/ced/llaf343)
- Vyas, J. et al. 2024. A systematic review of 207 studies describing validation aspects of the dermatology life quality index. Acta Dermato-Venereologica 104 adv41120. (10.2340/actadv.v104.41120)
- Vyas, J. et al. 2024. A systematic review of 457 randomised controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries. British Journal of Dermatology 190 (3), pp.315-339. (10.1093/bjd/ljad079)
- Wójcik, E. et al., 2021. Major life changing decision profile: Creation of the Polish language version. Dermatologic Therapy 34 (1) e14568. (10.1111/dth.14568)
Thesis